Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$200.61 USD
-1.07 (-0.53%)
Updated Dec 4, 2023 04:00 PM ET
After-Market: $200.64 +0.03 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/28/2024
Time: -- |
12/2023 | $2.42 | -1.53% |
Earnings Summary
For their last quarter, Charles River Laboratories International (CRL) reported earnings of $2.72 per share, beating the Zacks Consensus Estimate of $2.35 per share. This reflects a positive earnings surprise of 15.74%. Look out for CRL's next earnings release expected on February 28, 2024. For the next earning release, we expect the company to report earnings of $2.42 per share, reflecting a year-over-year decrease of 18.79%.
Earnings History
Price & Consensus
Zacks News for CRL
Charles River (CRL) Backs the Quest to Cure SPG56 via New Deal
CRL: What are Zacks experts saying now?
Zacks Private Portfolio Services